Shu Dong XIAO

3.2k total citations
77 papers, 2.5k citations indexed

About

Shu Dong XIAO is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shu Dong XIAO has authored 77 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 32 papers in Surgery and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shu Dong XIAO's work include Helicobacter pylori-related gastroenterology studies (23 papers), Gastric Cancer Management and Outcomes (17 papers) and Eosinophilic Esophagitis (10 papers). Shu Dong XIAO is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (23 papers), Gastric Cancer Management and Outcomes (17 papers) and Eosinophilic Esophagitis (10 papers). Shu Dong XIAO collaborates with scholars based in China, United States and Singapore. Shu Dong XIAO's co-authors include Zhi Hua Ran, Sheng Zhong, Jin Lu Tong, Jing‐Yuan Fang, Xiaoyi Cao, Xi Xu, Wen Zhong Liu, Dan Xie, Pengfei Yu and Fang Nie and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Shu Dong XIAO

72 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Dong XIAO China 27 1.1k 869 514 367 315 77 2.5k
Doerthe Kuester Germany 28 649 0.6× 850 1.0× 447 0.9× 373 1.0× 270 0.9× 83 2.3k
Ken‐ichi Katsu Japan 25 686 0.7× 745 0.9× 310 0.6× 296 0.8× 200 0.6× 106 2.2k
Katerina Dvorak United States 24 663 0.6× 707 0.8× 382 0.7× 345 0.9× 184 0.6× 51 1.8k
Sung Wook Hwang South Korea 27 824 0.8× 771 0.9× 474 0.9× 503 1.4× 281 0.9× 174 2.8k
Masami Inada Japan 20 485 0.5× 675 0.8× 277 0.5× 352 1.0× 105 0.3× 107 1.9k
Benjamin Chun–Yu Wong Hong Kong 32 830 0.8× 1.5k 1.7× 883 1.7× 429 1.2× 410 1.3× 53 4.0k
Osamu Tsuruta Japan 24 373 0.4× 637 0.7× 637 1.2× 705 1.9× 241 0.8× 108 2.0k
M. Anti Italy 28 1.0k 1.0× 895 1.0× 340 0.7× 944 2.6× 342 1.1× 65 3.1k
Kai‐Feng Pan China 31 1.3k 1.2× 2.0k 2.3× 1.2k 2.4× 569 1.6× 283 0.9× 105 3.8k
Hiromasa Takaishi Japan 27 797 0.8× 414 0.5× 255 0.5× 679 1.9× 102 0.3× 89 2.2k

Countries citing papers authored by Shu Dong XIAO

Since Specialization
Citations

This map shows the geographic impact of Shu Dong XIAO's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Dong XIAO with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Dong XIAO more than expected).

Fields of papers citing papers by Shu Dong XIAO

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Dong XIAO. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Dong XIAO. The network helps show where Shu Dong XIAO may publish in the future.

Co-authorship network of co-authors of Shu Dong XIAO

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Dong XIAO. A scholar is included among the top collaborators of Shu Dong XIAO based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Dong XIAO. Shu Dong XIAO is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Tri C., Xiaoyi Cao, Pengfei Yu, et al.. (2016). Mapping RNA–RNA interactome and RNA structure in vivo by MARIO. Nature Communications. 7(1). 12023–12023. 120 indexed citations
2.
XIAO, Shu Dong, Xiaoyi Cao, & Sheng Zhong. (2014). Comparative epigenomics: defining and utilizing epigenomic variations across species, time‐course, and individuals. WIREs Systems Biology and Medicine. 6(5). 345–352. 5 indexed citations
3.
Xu, Gui‐Ping, et al.. (2013). Rig-G negatively regulates SCF-E3 ligase activities by disrupting the assembly of COP9 signalosome complex. Biochemical and Biophysical Research Communications. 432(3). 425–430. 11 indexed citations
4.
Yu, Pengfei, Shu Dong XIAO, Xiaoyun Xin, et al.. (2012). Spatiotemporal clustering of the epigenome reveals rules of dynamic gene regulation. Genome Research. 23(2). 352–364. 52 indexed citations
5.
XIAO, Shu Dong. (2011). Words from Editor‐in‐Chief of the Journal of Digestive Diseases. Journal of Digestive Diseases. 13(1). 1–1. 1 indexed citations
7.
Xu, Xi, Qi Xu, Jin Lu Tong, et al.. (2011). Meta‐analysis: Circulating adiponectin levels and risk of colorectal cancer and adenoma. Journal of Digestive Diseases. 12(4). 234–244. 65 indexed citations
8.
Zheng, Qing, et al.. (2010). Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance. Journal of Digestive Diseases. 11(5). 313–318. 55 indexed citations
9.
Gao, Yun, et al.. (2010). Endoscopic capsule placement improves the completion rate of small-bowel capsule endoscopy and increases diagnostic yield. Gastrointestinal Endoscopy. 72(1). 103–108. 31 indexed citations
10.
Xie, Dan, Leon M. Ptaszek, Shu Dong XIAO, et al.. (2010). Rewirable gene regulatory networks in the preimplantation embryonic development of three mammalian species. Genome Research. 20(6). 804–815. 175 indexed citations
11.
XIAO, Shu Dong. (2009). Observation on Therapeutic Effects of IVIG and mNGF Cure for the Children with Guillain-Barré Syndrome.
12.
Ran, Zhi Hua, Yao Yuan, Zhao Shen Li, et al.. (2009). The efficacy of Combizym in the treatment of Chinese patients with dyspepsia: a multicenter, randomized, placebo‐controlled and cross‐over study. Journal of Digestive Diseases. 10(1). 41–48. 7 indexed citations
13.
Ran, Zhi Hua, Chi Chen, & Shu Dong XIAO. (2008). Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid. Biomedicine & Pharmacotherapy. 62(3). 189–196. 75 indexed citations
14.
Hu, Pin Jin, et al.. (2008). Third Chinese National Consensus Report on the management of Helicobacter pylori infection1
(August 2007, Lushan, Jiangxi Province, China). Journal of Digestive Diseases. 9(3). 178–184. 111 indexed citations
16.
Zheng, Qing, Yan Pan, Lin Zhang, & Shu Dong XIAO. (2005). Comparison of the efficacy of 1‐day high‐dose quadruple therapy versus 7‐day triple therapy for treatment of Helicobacter pylori infection. PubMed. 6(4). 202–205. 5 indexed citations
17.
Zheng, Qing, Xiao Yu Chen, Yao Shi, & Shu Dong XIAO. (2004). Development of gastric adenocarcinoma in Mongolian gerbils after long‐term infection with Helicobacter pylori. Journal of Gastroenterology and Hepatology. 19(10). 1192–1198. 40 indexed citations
18.
Fang, Jing‐Yuan & Shu Dong XIAO. (2003). Folic acid, polymorphism of methyl-group metabolism genes, and DNA methylation in relation to GI carcinogenesis. Journal of Gastroenterology. 38(9). 821–829. 62 indexed citations
19.
XIAO, Shu Dong, et al.. (2001). Alteration of DNA methylation in gastrointestinal carcinogenesis. Journal of Gastroenterology and Hepatology. 16(9). 960–968. 39 indexed citations
20.
XIAO, Shu Dong, et al.. (1997). A preliminary analysis of antineoplastic activity of parvovirus MVMp NS-1 proteins. Cell Research. 7(2). 217–227. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026